Introduction {#S1}
============

One new case of stroke occurs every 40 s in the United States alone ([@B33]). Less than 50% of people who suffer a stroke will return to independent living within a year ([@B43]), and even those who regain functional independence will often continue to manifest significant physical and cognitive deficits ([@B35]). Not only does stroke increase the risk of early death by twofold, but individuals with significant physical and cognitive impairments post-stroke have even greater mortality-risk and are more likely to suffer a second catastrophic stroke ([@B57]). Thus, identifying modifiable risk-factors to maintain and possibly restore the health of adults post-stroke is critical.

Increasing physical activity (PA) may be critical to maintain and restore health post-stroke ([@B44]). Strong epidemiological evidence consistently indicates that engaging in ≥150 min/week of PA of at least 3.0 metabolic equivalents (METs) is associated with increased life span and reduced risk of chronic conditions including stroke, dementia, and diabetes mellitus ([@B8]; [@B47]; [@B7]; [@B34]). While the importance of PA for health is well established, decreases in PA are a common consequence of stroke ([@B45]; [@B20]; [@B26]). For example, it is estimated that adults with stroke take over 4000 fewer steps per day than their healthy peers ([@B26]). Decreases in PA levels after stroke can also lead to disuse atrophy and cardiovascular deconditioning, which combined with social isolation and associated psychological factors can lead to an increased risk for secondary cardiac complications and recurrent stroke ([@B5]).

Reducing sedentary behavior (SB)---defined as any behavior that incurs ≤1.5 METs such as sitting, television watching, and lying down ([@B51])---may also be an important modifiable risk factor following stroke. There is mounting evidence that high SB is linked to a greater risk of early death ([@B6]), diabetes mellitus ([@B50]), cardiovascular disease ([@B29]), and cognitive decline ([@B22]). Importantly, recent epidemiological data suggests adults with stroke spend more than 10 h/day in SB, and 1.2 h/day more than their non-stroke peers ([@B11]). Although little is known about the consequences of high SB following a stroke, high SB is a risk factor for stroke independent of PA ([@B14]), which suggests that reducing SB among adults with stroke may help maintain the health of this population.

Importantly, there is increasing evidence that PA (and to a lesser extent SB) each play a key role in the preservation of cognitive health post-stroke. Considerable evidence indicates greater amounts of PA improves cognitive function and reduces dementia risk ([@B15]; [@B34]), and increasing PA among adults with stroke can significantly improve cognitive function ([@B17]). Adults with higher SB also have poorer cognitive performance in later life ([@B22]), and thus it is likely that high SB is a risk factor for further cognitive decline in adults with stroke. While PA and SB may each have important implications on cognitive health, there is mounting evidence that there is also a dynamic relationship between PA and SB ([@B38]; [@B50]), which may directly influence cognitive function. It is thus important to concurrently examine the implications of each of these behaviors on cognitive health---and each other ([@B41]; [@B23]).

Given the aforementioned evidence, and the knowledge that stroke doubles the risk of all-cause dementia ([@B53]), the need to understand how PA and SB impacts the cognitive health of adults with stroke is clear. Doing so requires the availability of well-designed tools, with good evidence of validity and reliability, which are capable of measuring PA and SB concomitantly. One such measure is the MotionWatch8© (MW8), which has evidence of validity and reliability for measuring PA and SB in healthy older adults ([@B41]; [@B23]). However, it is important that a measure have evidence of validity and reliability for the population which one intends to observe ([@B25]). Wrist-worn actigraphy has potential as a tool for measuring PA and SB in adults with stroke ([@B42]), however adults with stroke expend more energy during walking than their healthy peers ([@B40]). It is thus plausible that not only does the MW8 require a different calibration for adults with stroke, but that the side of the body which the MW8 is worn, and the severity of stroke require different calibrations of the device. As a first step toward creating a valid and reliable measure for objectively monitoring PA and SB concomitantly in adults with stroke, we set out to (1) calibrate and validate cut-points for PA and SB for adults with stroke; (2) determine if different cut-points are required based on which side of the body the MW8 is placed; and (3) determine if different cut-points are required for adults with mild stroke as compared to adults with moderate-to-severe stroke.

Materials and Methods {#S2}
=====================

Ethical approval was obtained from the Vancouver Coastal Health Research Institute and the University of British Columbia's Clinical Research Ethics Board (H13-00715). All participants provided written informed consent.

Participants {#S2.SS1}
------------

Adults with chronic stroke (*N* = 43) were recruited from an ongoing 6-month proof-of-concept randomized controlled trial (RCT) to improve cognitive function in adults with stroke ([@B4]). Participants were recruited from the RCT following baseline assessment. Briefly, our sample of adults with stroke consisted of community-dwelling men and women: (1) aged 55 years and older; (2) who had an ischemic or hemorrhagic stroke (confirmed by previous MRI or computed tomography scan) at least 1 year prior to study enrollment; (3) Mini-Mental State Examination (MMSE) score of ≥20/30 ([@B28]); (4) able to read, write, and speak English with acceptable visual and auditory acuity; (5) not expected to start or are stable on a fixed dose of cognitive medications (e.g., donepezil, galantamine, etc.); (6) able to walk ≥6 m with rest intervals; (7) not currently participating in any regular therapy or progressive exercise; and (8) not diagnosed with dementia of any type, or another neurodegenerative or neurological condition. Individuals interested in participating in the study were pre-screened for eligibility criteria. We included individuals in the study who: (1) were cleared for exercise using the modified Physical Activity Readiness Questionnaire (Modified PAR-Q; [@B13]; [@B12]) and could walk independently with or without a walking aid. We excluded participants who were unable to wear a portable indirect calorimeter during testing.

Measures {#S2.SS2}
--------

### Demographics {#S2.SS2.SSS1}

Participants were surveyed via questionnaire for their age, sex, race, and ethnicity; as well as any current or previous health conditions such as diabetes, hypertension, osteoporosis, arthritis, and cancer. We recorded whether participants used a cane or other ambulatory device, and height and body weight (as measured by a calibrated stadiometer and electronic scale, respectively) were used to determine each participant's body mass index (BMI; kg/m2). In addition, we assessed participant motor function using the Fugl Meyer motor score ([@B30]; [@B32]). Participants were scored on a scale of 0--100; 0--66 for the upper body, and 0--34 for the lower body.

### Wrist Worn Accelerometer {#S2.SS2.SSS2}

We used the MW8 actigraphy system (cam*n*tech): a light weight, water-proof, tri-axial wrist-worn accelerometer. The protocol in our previous MW8 validation study was to place the device on the non-dominant wrist (a standard procedure; [@B41]), however, we modified this protocol such that participant wore a MW8 on each wrist (i.e., stroke affected side and non-affected side). MW8 data were recorded using 60 s epochs.

### Indirect Calorimeter {#S2.SS2.SSS3}

As our criterion measure, we used the Cosmed k4b2, a portable indirect calorimeter (Cosmed; Rome, Italy) to determine energy expenditure during each assessment. Indirect calorimetry is used to measure oxygen uptake (VO~2~) and production of carbon dioxide (VCO~2~). Inspired and expired gases are collected via a breathing mask and then analyzed to determine VO~2~ and VCO~2~ volumes. These measurements are used to determine energy expenditure in the form of metabolic equivalents (METs) via Schofield-equations ([@B55]). Briefly, Schofield-equations estimate metabolic rate according to weight, age and sex; these estimates of metabolic rate are then used to classify an activity based on the METs it requires. In accordance with established guidelines ([@B51]), activities were classified as follows: (1) sedentary (\<1.5 METs); (2) light (1.5--3.0 METs), or moderate-to-vigorous PA (MVPA; \>3.0 METs).

Measurement Protocol {#S2.SS3}
--------------------

The Cosmed gas analyzers were calibrated and verified with known gases immediately before and after each test. Following calibration completion, the Cosmed was fitted for comfort to each participant. The Cosmed was worn concurrently with MW8's equipped on the wrist of the stroke affected side and the non-affected side.

Measurement of METs was recorded at 60 s intervals on the indirect calorimeter. The METs data from each session were downloaded into Microsoft Excel for further processing. To ensure consistency across measurement sessions, two assessors (RSF and MCRL) -- who were previously trained on all aspects of the measurement protocol -- calibrated the Cosmed and conducted the trials for all participants. All instruments were synchronized to the same clock, and time was recorded at the beginning and end of each activity to ensure appropriate data comparisons could be made across recording devices. For all sessions, notes on participant activity during the trial were documented.

The measurement session lasted ∼60 min, during which each participant performed 10 different activities designed to mimic activities of daily living: (1) walking at four different paces; (2) sitting in a chair; (3) cleaning; (4) resistance training; (5) lying down; and (6) standing. To more closely mimic free-living activity, participants were allowed to move their arms freely during these activities, however, the measurement session occurred in a quiet room. Participants were provided standardized instructions (as per a predetermined script), prior to beginning each activity. As described below, participants performed 10 activities -- for 5 min each -- in the following order:

### Walking {#S2.SS3.SSS1}

Participants were asked to walk at four different speeds around a circular hallway (∼50 meters in circumference), with each speed intended to mimic a specific pace: *Leisurely, Comfortable, Moderate*, and *Brisk*. Participants self-selected the speed for each pace, as described below. This was done for safety reasons, as well as to adjust for variability in fitness level across participants. Once the speed had been selected for each pace, the participant was asked to maintain this pace for 5 min. While we did not require participants to be able to walk 5 min without stopping, only two participants required a break of \<1 min during the *Brisk Pace* condition. After walking for 5 min at a given pace, participants were given a 2 min recovery period, during which they could sit down. The following order was used for each self-selected pace:

#### Leisurely pace {#S2.SS3.SSS1.Px1}

Participants were first instructed to walk at a leisurely pace. This speed was described as a pace the participant would walk at during a casual walk with a friend. Participants were instructed this pace was supposed to be easy, requiring minimal exertion.

#### Comfortable pace {#S2.SS3.SSS1.Px2}

Participants were instructed to walk at a pace they would use for a little light exercise. This walking speed was described as being faster than the previous speed, but requiring limited exertion.

#### Moderate pace {#S2.SS3.SSS1.Px3}

Participants were instructed to walk at a pace they would use for moderate exercise or when completing an errand. Participants were instructed to walk at a quick pace, so they would walk with purpose but not urgency.

#### Brisk pace {#S2.SS3.SSS1.Px4}

This speed was described as a pace the participant would walk if they were running late or needed to get somewhere as fast as possible. It was intended to be the fastest pace the participant could walk at for 5 min without slowing down.

### Sitting {#S2.SS3.SSS2}

Participants were instructed to sit in a chair. No instructions were given as to how they must sit, but they were asked to remain seated for the entire 5 min. Typically, the experimenter and participant engaged in polite conversation during this time.

### Cleaning {#S2.SS3.SSS3}

Participants were led to a sink, where they were provided soap to wash three plates and three cups. Participants were told to wash the provided dishes as they normally would in their own home. Participants were asked to wash the provided dishes continuously for the duration of 5 min.

### Resistance Training {#S2.SS3.SSS4}

Participants engaged in two resistance training activities that are typical for resistance training programs: Bicep Curls and Chair Squats. Participants completed three sets of 10 repetitions for each exercise. Rest between sets of each exercise was permitted as needed.

#### Bicep curls {#S2.SS3.SSS4.Px1}

Instructions were provided as needed to ensure participants performed all bicep curls using proper technique in a slow and controlled manner while sitting. Five-pound dumbbells and ten-pound dumbbells were used by women and men, respectively. In cases where a participant was unable to complete bicep curls with the stroke affected arm, the participant was asked (to the best of their ability) to grip one dumbbell with both hands and perform a bicep curl with both hands holding the dumbbell.

#### Chair squats {#S2.SS3.SSS4.Px2}

This required participants to sit down in a chair and then stand up to complete one repetition. Participants did not use weights for this task, and were allowed to use the arm rests of the chair as needed.

### Lying Down {#S2.SS3.SSS5}

Participants were instructed to lie down on a bed for a period of 5 min.

### Standing {#S2.SS3.SSS6}

Participants were asked to remain standing for 5 min, but were given the option to move around the room freely. No additional instructions were given during this time as this period was intended to mimic standing and free-movement as part of routine daily activity. Following completion of this activity, the trial was terminated.

Statistical Analysis {#S2.SS4}
--------------------

We performed all statistical analyses in R version 3.3.2 using the *readxl, pastecs, psych, plyr, pROC*, and *BlandAltmanLeh* packages. Our statistical code is available in [Supplementary Material S1](#SM1){ref-type="supplementary-material"}.

### Stratification and Demographics {#S2.SS4.SSS1}

In order to account for potential differences in motor function due to stroke severity, we stratified participants based on Fugl Meyer motor score according to the criteria of [@B19]. We calculated means and standard deviations for all variables of interest for all participants, and then separately for participants with mild stroke (Fugl Meyer ≥ 79/100; *N* = 29) or moderate-to-severe stroke (Fugl Meyer \< 79; *N* = 14). We then performed independent samples *t*-tests and chi-square tests to determine group differences in demographic variables of interest.

### Agreement Analyses {#S2.SS4.SSS2}

We determined the level of agreement of the MW8 when placed on the stroke affected side as compared to the non-affected side. Data from the left and right MW8 were summarized and compared using partial Pearson correlations (*r*) wherein we controlled for the participant assessed, and intra-class correlations (ICC; \[3, *k*\]) to assess average agreement between the MW8 placed on the stroke affected side and the MW8 placed on the non-affected side over different levels of activity. A higher *r* and/or ICC is indicative of greater agreement. We categorized the level of agreement according to the criteria of [@B39]. In addition, we generated Bland-Altman plots to determine agreement over different intensities of activity between the MW8 placed on the stroke affected side and the MW8 placed on the non-affected side ([@B9]). We performed these agreement analyses for all participants, as well as stratified based on stroke severity (i.e., mild stroke vs. moderate-to-severe stroke).

### Determining Optimal Cut-Points for the MW8 {#S2.SS4.SSS3}

Our primary objective was to derive MW8 activity count cut-points for adults with stroke for SB, light PA (LPA), and moderate-to-vigorous PA (MVPA). We derived two separate sets of cut-points for the MW8---one for the stroke affected side, and one for the non-affected side. For each set of cut-points, receiver operator characteristics (ROC) analyses ([@B3]) were performed to determine optimal cut-points for the following intensities: SB (\<1.5 METs), LPA (1.5 -- 3.0 METs); and MVPA (\>3.0 METs) ([@B46]; [@B51]). For each ROC curve, METs were coded as 0 or 1 according to the cut-point being established. For example, when the sedentary cut-point was being established, a "1" was assigned to all minutes wherein a participant was reported in SB via indirect calorimetry and a "0" was assigned to all minutes wherein a participant was not reported in SB based on indirect calorimetry. The area under the ROC curve (AUC) was calculated for both SB and MVPA. We categorized the diagnostic accuracy of the AUC using the criteria of [@B27]. In addition, we determined whether the diagnostic accuracy of the AUC was significantly different between the non-affected and the affected sides using DeLong's test for two correlated ROC curves ([@B18]).

*Sensitivity, Specificity, Accuracy, Positive Predictive Value*, and *Negative Predictive Value* were calculated for both the SB and MVPA cut-points. *Sensitivity* is the percentage of epochs correctly identified as being engaged at the activity level examined (e.g., percent of actual MVPA epochs correctly identified as an epoch of MVPA). *Specificity* is the percentage of epochs correctly identified as not being engaged at the activity level examined (e.g., percent of actual non-MVPA epochs correctly identified as not being an epoch of MVPA). *Accuracy* is defined as the percent of correct decisions made using the derived cut-point (e.g., percent correctly identified as MVPA and percent correctly identified as non-MVPA). *Positive Predictive Value* is the probability of correctly identifying an epoch as being engaged at that activity level, given that it truly is an epoch of that activity level (e.g., probability of correctly identifying an epoch of MVPA as MVPA). *Negative Predictive Value* is the probability of correctly identifying an epoch as not being engaged at that activity level, given that it truly is not an epoch of that activity level (e.g., the probability of correctly identifying an epoch of sedentary activity as not being MVPA).

Optimal cut-points were established for SB using the Youden index (*J*; [@B1]). Briefly, *J* is defined as the maximum vertical distance between the ROC curve and the diagonal (i.e., chance line) and is calculated as *J* = maximum \[sensitivity + specificity -- 100\]. Using this measure, the maximum value for *J* is considered to be the optimal cut-point. Cut-points for MVPA were established using the highest *J* given a false-positive-ratio \< 0.10. We derived cut-points using this approach to prevent overestimation and provide a more conservative estimate of MVPA. The cut-point for LPA was determined as the activity level between the boundaries for SB and MVPA.

After determining separate cut-points for each activity type for all participants, we then proceeded to develop separate cut-points based on stroke severity (i.e., mild stroke vs. moderate-to-severe stroke). Thus, we derived six separate sets of cut-points: two for all participants (i.e., stroke affected side or non-affected side), two for participants with mild stroke, and two for participants with moderate-to-severe stroke.

Results {#S3}
=======

Participant Characteristics {#S3.SS1}
---------------------------

Participant characteristics are described in [Table 1](#T1){ref-type="table"}. Mean participant age was 67 years (*SD* = 7 years), mean BMI was 27.17 kg/m^2^ (*SD* = 5.25 kg/m^2^) and 35% of our sample was female. In addition, 56% of our sample required a cane or a walker. Average Fugl Meyer motor score for the sample was 78 (*SD* = 22; Range: 8--98). When we stratified participants according to stroke severity, there were no significant group differences in age, BMI, or sex. Participants with moderate-to-severe stroke had significantly poorer Fugl Meyer upper body motor score (Moderate-to-Severe Stroke: 30 \[*SD* = 17\]; Mild Stroke: 62 \[*SD* = 5\]; *p* \< 0.01) and significantly poorer total score (Moderate-to-Severe Stroke: 54 \[*SD* = 22\]; Mild Stroke: 90 \[*SD* = 5\]; *p* \< 0.01).

###### 

Participant characteristics (*N* = 43).

  Variable                     All Participants (*N* = 43)   Adults with Moderate-to-Severe Stroke (*N* = 14)   Participants with Mild Stroke (*N* = 29)   *p-value*
  ---------------------------- ----------------------------- -------------------------------------------------- ------------------------------------------ -----------
  Age                          67 (7)                        70 (9)                                             67 (6)                                     0.20
  BMI (kg/m^2^)                27.17 (5.25)                  26.63 (2.66)                                       27.43 (6.15)                               0.55
  \% Female                    35%                           29%                                                38%                                        0.79
  **Race**                                                                                                                                                 
  *Caucasian*                  72%                           64%                                                76%                                        0.60
  *Asian*                      14%                           14%                                                14%                                        
  *Other*                      14%                           22%                                                10%                                        
  **Comorbidities**                                                                                                                                        
  *Diabetes Mellitus*          19%                           36%                                                10%                                        0.13
  *Cancer*                     14%                           14%                                                14%                                        0.99
  *Osteoporosis*               14%                           14%                                                14%                                        0.99
  **Mobility assistance**                                                                                                                                  
  *Use a cane*                 56%                           64%                                                48%                                        0.20
  *Use a walker*               2%                            7%                                                 0%                                         
  **Fugl Meyer Motor Score**                                                                                                                               
  *Upper Body (66 points)*     51 (18)                       30 (17)                                            62 (5)                                     \<0.01
  *Lower Body (34 points)*     27 (6)                        24 (8)                                             29 (4)                                     0.07
  *Total Score (100 points)*   78 (22)                       54 (22)                                            90 (5)                                     \<0.01

Agreement Analyses {#S3.SS2}
------------------

[Table 2](#T2){ref-type="table"} describes the agreement of the MW8 when placed on the stroke affected side as compared to the non-affected side for all participants, adults with mild stroke, and adults with moderate-to-severe stroke.

###### 

Agreement of the MotionWatch8 for adults with stroke.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                     Watch Side             Number of Epochs   Mean counts per minute (*SD*) \[Range\]   Pearson Correlation   Interclass Correlations (95% CI)
  -------------------------------------------------- ---------------------- ------------------ ----------------------------------------- --------------------- ----------------------------------
  All Participants (*N* = 43)                        Stroke Affected Side   2277               377 (443)\                                0.53                  0.68 (0.65, 0.70)
                                                                                               \[0--3617\]                                                     

                                                     Non-Affected Side      2277               408 (396)\                                --                    --
                                                                                               \[0--2591\]                                                     

  Adults with Mild Stroke (*N* = 29)                 Stroke Affected Side   1527               410 (469)\                                0.51                  0.65 (0.61, 0.68)
                                                                                               \[0--3617\]                                                     

                                                     Non-Affected Side      1527               392 (381)\                                --                    --
                                                                                               \[0--2591\]                                                     

  Adults with Moderate-to-Severe Stroke (*N* = 14)   Stroke Affected Side   750                310 (374)\                                0.60                  0.77 (0.73, 0.80)
                                                                                               \[0--2043\]                                                     

                                                     Non-Affected Side      750                440 (421)\                                --                    --
                                                                                               \[0--2318\]                                                     
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### All Participants (*N* = 43*)* {#S3.SS2.SSS1}

A total of 2277 total epochs were captured for all participants on each of the MW8s worn (i.e., on the wrist of the stroke affected side and on the wrist of the non-affected side). There was a moderate correlation between CPM measured by each of the MW8 (*r* = 0.53). The ICC assessing consistency of the measures provided by each MW8 indicated moderate agreement (ICC = 0.68; 95% CI \[0.65, 0.70\]). As shown in [Figure 1](#F1){ref-type="fig"}, the average difference between MW8s (i.e., stroke affected side -- non-affected side) was -31 CPM (*SD* = 414 CPM). In addition, there was greater disagreement between the affected side and the non-affected side with higher CPM.

![Bland--Altman plots for agreement of the MotionWatch8 for **(A)** all participants (*N* = 43); **(B)** participants with mild stroke (*N* = 29); and **(C)** participants with moderate-to-severe stroke (*N* = 14). Differences between counts reported by the stroke affected side MW8 and the stroke non-affected side MW8 are reported. A greater amount of activity was associated with less agreement between the affected side MW8 and non-affected side MW8, irrespective of stroke severity. Dotted lines represent upper and lower limits of agreement. ULOA: Upper Limit of Agreement; LLOA: Lower Limit of Agreement.](fnagi-11-00203-g001){#F1}

### Adults With Mild Stroke (*N* = 29) {#S3.SS2.SSS2}

Among participants with mild stroke, we collected 1527 epochs on each of the MW8s worn ([Table 2](#T2){ref-type="table"}). There was a moderate correlation between CPM measured by each of the MW8 (*r* = 0.51). The ICC assessing consistency of the measures provided by each MW8 indicated moderate agreement (ICC = 0.65; 95% CI \[0.61, 0.68\]). The average difference between MW8s was 18 CPM (*SD* = 436 CPM), as detailed in [Figure 1](#F1){ref-type="fig"}, and there was greater disagreement between the affected side and the non-affected side with higher CPM.

### Adults With Moderate-to-Severe Stroke (*N* = 14) {#S3.SS2.SSS3}

Among participants with moderate-to-severe stroke, we collected 750 epochs on each of the MW8s worn ([Table 2](#T2){ref-type="table"}). There was a moderate correlation between CPM measured by each of the MW8 (*r* = 0.60). The ICC assessing consistency of the measures provided by each MW8 indicated good agreement (ICC = 0.77; 95% CI \[0.73, 0.80\]). The average difference between MW8s was −130 CPM (*SD* = 345 CPM; [Figure 1](#F1){ref-type="fig"}). In addition, we found greater disagreement between the affected side and the non-affected side with higher CPM.

ROC Curve Analyses {#S3.SS3}
------------------

### ROC Curve Analysis for All Participants {#S3.SS3.SSS1}

[Figure 2](#F2){ref-type="fig"} describes the ROC curves for SB and MVPA respectively for all participants. On the non-affected side, the AUC for the ROC curve was moderately accurate for SB (AUC = 0.78; 95% CI \[0.75, 0.80\]) and moderately accurate for MVPA (AUC = 0.76; 95% CI \[0.74, 0.78\]). On the stroke affected side, the AUC for the ROC curve was moderately accurate for SB (AUC = 0.81; 95% CI \[0.79, 0.83\]) and moderately accurate for MVPA (AUC = 0.79; 95% CI \[0.77, 0.81\]). The AUC for the stroke affected side was significantly greater for both the ROC curve for SB (*Z* = 3.47; *p* \< 0.01) and MVPA (*Z* = 3.83; *p* \< 0.01).

![Receiver operating characteristic (ROC) curves and corresponding area under the curves (with 95% confidence interval; AUC) for all participants (*N* = 43) with the MotionWatch8 (MW8) placed on either the non-affected side or the stroke affected side. **(A)** ROC curve for sedentary behavior with MW8 placed on the non-affected side (--) vs. affected side (- - -). We found there was moderate diagnostic accuracy for the non-affected side (AUC = 0.777; 95% CI: \[0.754--0.801\]), and moderate diagnostic accuracy for the affected side (AUC = 0.814; 95% CI: \[0.794--0.834\]). **(B)** ROC curve for moderate-to-vigorous physical activity with MW8 placed on the non-affected side (--) vs. affected side (- - -). We found there was moderate diagnostic accuracy for the non-affected side (AUC = 0.758; 95% CI: \[0.738 -- 0.779\]), and moderate diagnostic accuracy for the affected side (AUC = 0.792; 95% CI: \[0.773--0.810\]). ^\*^Significant difference in diagnostic accuracy between ROC curves ([@B18]).](fnagi-11-00203-g002){#F2}

### ROC Curve Analysis for Adults With Mild Stroke {#S3.SS3.SSS2}

[Figure 3](#F3){ref-type="fig"} describes the ROC curves for SB and MVPA respectively for participants with mild stroke. The AUC on the non-affected side for the ROC curve was moderately accurate for SB (AUC = 0.80; 95% CI \[0.77, 0.82\]) and moderately accurate for MVPA (AUC = 0.76; 95% CI \[0.74, 0.78\]). The AUC on the stroke affected side was moderately accurate for SB (AUC = 0.82; 95% CI \[0.80, 0.85\]) and moderately accurate for MVPA (AUC = 0.77; 95% CI \[0.74, 0.79\]). The AUC for the stroke affected side was marginally greater for the ROC curve of SB (Z = 1.959; *p* = 0.051), but was not significantly different for the ROC curve of MVPA (Z = 0.69; *p* = 0.49).

![Receiver operating characteristic (ROC) curves and corresponding area under the curves (with 95% confidence interval; AUC) for participants with mild stroke (*N* = 29) with the MotionWatch8 (MW8) placed on either the non-affected side or the stroke affected side. **(A)** ROC curve for sedentary behavior with MW8 placed on the non-affected side (--) vs. affected side (- - -). We found there was moderate diagnostic accuracy for the non-affected side (AUC = 0.795; 95% CI: \[0.766 -- 0.823\]), and moderate diagnostic accuracy for the affected side (AUC = 0.820; 95% CI: \[0.795--0.845\]). **(B)** ROC curve for moderate-to-vigorous physical activity with MW8 placed on the non-affected side (--) vs. affected side (- - -). We found there was moderate diagnostic accuracy for the non-affected side (AUC = 0.759; 95% CI: \[0.735--0.784\]), and moderate diagnostic accuracy for the affected side (AUC = 0.766; 95% CI: \[0.742--0.790\]).](fnagi-11-00203-g003){#F3}

### ROC Curve Analysis for Adults With Moderate-to-Severe Stroke {#S3.SS3.SSS3}

[Figure 4](#F4){ref-type="fig"} describes the ROC curves for SB and MVPA respectively for participants with moderate-to-severe stroke. The AUC on the non-affected side was moderately accurate for SB (AUC = 0.75; 95% CI \[0.71, 0.79\]) and moderately accurate for MVPA (AUC = 0.76; 95% CI \[0.72, 0.80\]). The AUC on the stroke affected side was moderately accurate for SB (AUC = 0.80; 95% CI \[0.77, 0.84\]) and moderately accurate for MVPA (AUC = 0.84; 95% CI \[0.81, 0.87\]). The AUC for the stroke affected side was significantly greater for both the ROC curve for SB (Z = 3.16; *p* \< 0.01) and MVPA (Z = 4.96; *p* \< 0.01).

![Receiver operating characteristic (ROC) curves and corresponding area under the curves (with 95% confidence interval; AUC) for participants with moderate-to-severe stroke (*N* = 14) with the MotionWatch8 (MW8) placed on either the non-affected side or the stroke affected side. **(A)** ROC curve for sedentary behavior with MW8 placed on the non-affected side (--) vs. affected side (- - -). We found there was moderate diagnostic accuracy for the non-affected side (AUC = 0.748; 95% CI: \[0.708--0.788\]), and moderate diagnostic accuracy for the affected side (AUC = 0.804; 95% CI: \[0.771--0.837\]). **(B)** ROC curve for moderate-to-vigorous physical activity with MW8 placed on the non-affected side (--) vs. affected side (- - -). We found there was moderate diagnostic accuracy for the non-affected side (AUC = 0.760; 95% CI: \[0.723--0.797\]), and moderate diagnostic accuracy for the affected side (AUC = 0.839; 95% CI: \[0.809--0.869\]). ^\*^Significant difference in diagnostic accuracy between ROC curves ([@B18]).](fnagi-11-00203-g004){#F4}

Determining Optimal MW8 Cut-Points for Adults With Stroke {#S3.SS4}
---------------------------------------------------------

[Table 3](#T3){ref-type="table"} describes the optimum cut-points for SB and MVPA with LPA being between those boundaries.

###### 

Cut-points for MotionWatch8 dependent on wrist-placement.

                                                Activity Level          Cut-point           Sensitivity   Specificity   Accuracy   Youden Index   Positive Predictive Value   Negative Predictive Value
  --------------------------------------------- ----------------------- ------------------- ------------- ------------- ---------- -------------- --------------------------- ---------------------------
  All Participants (*N* = 43)                   **Non-affected Side**                                                                                                         
                                                *Sedentary*             ≤165                69%           75%           74%        44.33          40%                         91%
                                                *Light*                 165 \< *x* \< 685   --            --            --         --             --                          --
                                                *MVPA*                  ≥685                38%           91%           73%        27.31          69%                         74%
                                                **Affected side**                                                                                                             
                                                *Sedentary*             ≤134                79%           71%           72%        49.35          39%                         93%
                                                *Light*                 134 \< *x* \< 652   --            --            --         --             --                          --
                                                *MVPA*                  ≥652                41%           90%           73%        30.76          68%                         74%
  Adults with Mild Stroke (*N* = 29)            **Non-affected Side**                                                                                                         
                                                *Sedentary*             ≤162                73%           76%           76%        49.53          42%                         92%
                                                *Light*                 162 \< *x* \< 661   --            --            --         --             --                          --
                                                *MVPA*                  ≥ 661               34%           90%           71%        24.70          66%                         72%
                                                **Affected Side**                                                                                                             
                                                *Sedentary*             ≤134                75%           75%           75%        50.33          41%                         93%
                                                *Light*                 134 \< *x* \< 704   --            --            --         --             --                          --
                                                *MVPA*                  ≥704                34%           90%           71%        24.13          65%                         72%
  Adults Moderate-to-Severe Stroke (*N* = 14)   **Non-affected Side**                                                                                                         
                                                *Sedentary*             ≤281                78%           61%           64%        39.00          33%                         92%
                                                *Light*                 281 \< *x* \< 738   --            --            --         --             --                          --
                                                *MVPA*                  ≥738                43%           90%           74%        32.57          68%                         76%
                                                **Affected Side**                                                                                                             
                                                *Sedentary*             ≤123                85%           63%           67%        48.33          37%                         95%
                                                *Light*                 123 \< *x* \< 468   --            --            --         --             --                          --
                                                *MVPA*                  ≥468                56%           90%           79%        46.13          74%                         81%

### Cut-Points for All Participants {#S3.SS4.SSS1}

For all participants independent of stroke severity, the cut-point for SB determined using the highest *J* was ≤165 CPM (*J* = 44.33) for the non-affected side and ≤134 CPM (*J* = 49.35) for the stroke affected side. After adjusting to target a false-positive ratio of ≤0.10, the derived cut-point for MVPA for the non-affected and stroke affected sides were ≥685 CPM (*J* = 27.31) and ≥652 CPM (*J* = 30.76), respectively.

### Cut-Points for Adults With Mild Stroke {#S3.SS4.SSS2}

For adults with mild stroke, the SB cut-point determined using the highest *J* was ≤ 162 CPM (*J* = 49.53) for the non-affected side and ≤134 CPM (*J* = 50.33) for the stroke affected side. After adjusting to target a false-positive ratio of ≤0.10, the cut-point for MVPA for the non-affected side was ≥661 CPM (*J* = 24.70) and the cut-point for the stroke affected side was ≥704 CPM (*J* = 24.13).

### Cut-Points for Adults With Moderate-to-Severe Stroke {#S3.SS4.SSS3}

The cut-points for SB for adults with moderate-to-severe stroke were ≤281 CPM (*J* = 39.00) and ≤123 CPM (*J* = 48.33), for the non-affected side and the stroke affected side respectively. After adjusting to target a false-positive ratio of ≤0.10, the cut-point for MVPA for the non-affected side was ≥738 CPM (*J* = 32.57) and the cut-point for the stroke affected side was ≥468 CPM (*J* = 46.13).

Discussion {#S4}
==========

The present study provides the first evidence of agreement and validity for estimating PA and SB using the MW8 among adults with stroke. Our results indicate that separate cut-points are needed dependent on whether the MW8 is placed on the stroke affected side or the non-affected side, and that adults with mild motor impairment from stroke should require different cut-points than adults with greater impairment.

While there is some evidence that wrist-worn accelerometers produces less accurate estimates of PA and SB than hip-worn accelerometers ([@B58]), the MW8 presents several distinct advantages as a measure for observing PA and SB ([@B41]; [@B23]). The MW8 is waterproof and does not need to be removed during activities such as bathing or swimming. The MW8 is specifically designed for comfortable, continuous wear during the day and at night, which improves wearer compliance and minimizes missing data. For example, in a cross-sectional study of 152 older adults ([@B24]), our laboratory only determined two instances of non-wear time with the MW8 according to the criteria of [@B36]. Finally, the MW8 might capture light activities better (i.e., household chores), especially those that do not involve the lower extremities.

Standard practice for measuring PA and SB using wrist-worn accelerometers has been to place the device on the non-dominant side ([@B16]; [@B37]). However, this protocol is challenging for adults with stroke if they have significant motor impairments since they may not be able to remove the device (if needed) or need to press an event-marker time stamp, which is often used to determine wake time from sleep time. Previous investigations of adults with stroke have thus used wrist-worn accelerometers on both the affected and non-affected side ([@B56]; [@B2]; [@B49]); however, these studies were not interested in PA, but rather sleep quality and upper limb movement. Recent work does indicate that wrist-worn accelerometers worn on either the stroke affected or non-affected side may be useful for examining PA of adults with acute stroke in an in-patient setting ([@B42]), but our study is the first to our knowledge which has examined the agreement and validity of wrist-worn accelerometers for measuring PA and SB among adults with chronic stroke.

While it is thus pragmatic to place the MW8 on the side of the body which improves wearability, the results of our agreement analyses indicate that the MW8 provides significantly different estimates of activity based on the side of the body on which the device is placed. Specifically, our Bland--Altman plots ([Figure 1](#F1){ref-type="fig"}) indicate that the device (1) has less consistency between the affected and non-affected sides as the activity intensity increases; and (2) has less consistency between the affected and non-affected sides for adults with moderate-to-severe stroke, as compared to adults with mild stroke. Given that the MW8 only has moderate agreement between the affected and non-affected sides according to the criteria of [@B39], researchers should try (whenever possible) to use a standardized protocol for determining which side of the body to place the MW8. This protocol should be based in part on the expected number of participants with significant impairments in mobility from stroke. Moreover, it is important that researchers determine the stroke severity of participants at baseline using the Fugl-Meyer ([@B30]; [@B32]).

The results of our cut-point analyses also suggest that researchers should carefully consider whether to place the MW8 on the affected or non-affected side of the body. While using the non-affected vs. affected side does not appear to significantly impact diagnostic accuracy of SB and MVPA for adults with mild stroke, using our cut-points for the affected side in adults with moderate-to-severe stroke appears to significantly improve diagnostic accuracy of SB and MVPA. Moreover, should researchers not determine stroke severity *a priori*, it appears that using the stroke affected side to estimate SB and MVPA will provide more accurate estimates of these behaviors.

Interestingly, our ICC results indicate that the MW8 has more consistent readings between the affected and non-affected sides in adults with moderate-to-severe stroke. One plausible explanation for this finding, as illustrated in [Table 2](#T2){ref-type="table"}, is the ranges of CPM (on both the affected and non-affected sides) for adults with moderate-to-severe stroke is considerably less than the range of CPM for adults with mild stroke. Given the similar ranges of CPM for the affected and non-affected sides in adults with moderate-to-severe stroke, it is likely that the agreement between the stroke affected and non-affected sides would be considerably more than for adults with mild stroke since the range of possible values is much smaller. However, our Bland--Altman plots ([Figure 1](#F1){ref-type="fig"}) illustrate that on average the affected side registers fewer CPM than the non-affected side for adults with moderate-to-severe stroke; there does not appear to be large differences in CPM between the affected and non-affected sides for adults with mild stroke. It is thus possible that while the consistency between the non-affected side and affected side is better for adults with moderate-to-severe stroke, there are considerable differences between the CPM output of the non-affected side and the affected side, and thus the MW8 requires different cut-points for both sides.

Our study thus provides an important step forward in the measurement of PA and SB for adults with stroke, since we provide validated cut-points for each of these behaviors using the MW8. Based on our findings, future investigations should consider both the side of the body on which the device is placed, as well as the severity of stroke when determining which of our cut-points to use.

Limitations {#S4.SS1}
-----------

Our study does have several important limitations. Our cut-points may be limited by inter-individual differences in physiological stress between participants. Numerous types of stressors including chronic illnesses, such as stroke, can affect energy expenditure (for review, see [@B52]). The MET definitions of SB and MVPA may differ for the population of adults with stroke, since adults with stroke typically have increased energy costs during walking and other activities of daily living ([@B40]). While wrist-worn accelerometry is a promising strategy for estimating PA and SB in adults with stroke since it may help improve wearability and compliance, use of these devices is not without limitations---particularly for measuring activity of the lower extremities (for review, see [@B31]; [@B49]). For example, wrist-worn accelerometers often measure unintentional activity which may be incorrectly classified as PA.

As we have previously acknowledged ([@B41]), the MW8 cut-points for PA and SB in healthy older adults lack the accuracy previously reported for the GENEA accelerometer ([@B21]); this is also likely true for adults with stroke. In addition, it is unclear how MW8 CPM are calibrated (e.g., do they reflect total motion CPM on a treadmill), and thus future research should determine whether CPM reflect (1) trunk movement while walking; (2) trunk movement with arm swing; or (3) arm swing but no trunk movement, and whether stroke-related paralysis effects CPM output. We did not account for whether VO~2~ had reached steady state in our analyses, which limit our ability to accurately predict whether an individual is actually engaged in SB or PA. It is also unclear how well MW8 CPM relates to energy expenditure, and whether the device more accurately predicts energy expenditure with the non-affected side as compared to the affected side in adults with stroke. Future work should thus examine the accuracy of the MW8 during different activities and energy expenditures.

Our primary aim was to establish cut-points for estimating SB and MVPA in adults with stroke using the MW8. While our secondary analyses examined whether different cut-points are needed based on stroke severity and which side of the body the device is placed, these analyses were exploratory in nature. We therefore did not perform an *a priori* sample size calculation, and thus cannot determine whether our secondary analyses were adequately powered to detect differences in diagnostic accuracy. We also did not examine the test-retest reliability of the MW8, and thus future studies should examine the repeatability of the estimates of SB and MVPA.

Standard practice is to ask participants to fast prior to indirect calorimetry assessment ([@B10]; [@B48]; [@B54]), however, because of concern for participant safety we did not ask participants to fast prior to the measurement session. Hence, it is possible that the accuracy of the MW8 for adults with stroke is less than that of other available devices, although the MW8's utility as a valid objective measure of both PA and SB, still make it an attractive tool for researchers working with adults with stroke. We expect the MW8 to be used frequently in future studies, and thus our cut-points should provide for increased depth of analysis in these studies.

Generalizability of our findings is also limited to MW8 use in adults with stroke. Nonetheless, we examined a heterogeneous sample of adults with stroke, both in terms of stroke type and location as well as motor impairment. Lastly, while we included adults with severe stroke as defined by the criteria of [@B19], our sample was of community-dwelling adults with stroke. Adults with stroke who have even more severe symptoms of stroke (e.g., tremor, severe paralysis, dysmetria, etc.) may require other measurement procedures than actigraphy to accurately estimate PA and SB.
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